Results 271 to 280 of about 112,118 (358)

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Transcatheter Aortic Valve Replacement for a Severe Aortic Valve Stenosis Coexisting with Hypertrophic Obstructive Cardiomyopathy - A Tale of Two Obstructions. [PDF]

Acta Cardiol Sin
Lin YS, Yu CL, Lee WL, Lin WW, Liang KW.
europepmc   +1 more source

A Novel Intronic Variant in the KH3 Domain of HNRNPK Leads to a Mild Form of Au‐Kline Syndrome

Clinical Genetics, EarlyView.
Integrated genomic and epigenomic analyses, associated with functional studies, confirm the pathogenicity of a novel HNRNPK variant in Au‐Kline syndrome (AKS). Our study underscores the value of DNA methylation signatures in variant interpretation, enhancing accurate diagnosis and clinical management of rare neurodevelopmental disorders.
Maura Mingoia, Alessandra Meloni, Silvia Sedda, Sanaa Choufani, Isadora Asunis, Giorgia Gemma, Antonio Ammendola, Arteen Torabi‐Marashi, Eleonora di Venere, Gabriella Maria Squeo, Vincenzo Rallo, Maria Giuseppina Marini, Paolo Moi, Salvatore Savasta, Rosanna Weksberg, Giuseppe Merla, Andrea Angius   +16 more
wiley   +1 more source

Diagnostic Challenges in the Management of Aortic Valve Stenosis and the Role of Imaging: A Narrative Review. [PDF]

J Clin Med
Karelas D, Tatsis E, Oikonomidis D, Papadopoulos CH.   +3 more
europepmc   +1 more source

Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery

, 2003
Giuseppe Tarantini
openalex   +1 more source

Secukinumab in the Treatment of Moderate‐to‐Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies

International Journal of Dermatology, EarlyView.
ABSTRACT Background Secukinumab, a fully human, monoclonal antibody targeting interleukin‐17A, is approved for moderate‐to‐severe HS in adults. This study evaluated pharmacokinetics (PK), high‐sensitivity C‐reactive protein (hsCRP) changes, and safety of secukinumab over 52 weeks in SUNSHINE and SUNRISE Phase 3 trials.
Afsaneh Alavi, Ziad Reguiai, Gregor B. E. Jemec, Alice B. Gottlieb, Magdalena B. Wozniak, Lorenz Uhlmann, Heng Fan, Angela Llobet Martinez, Gerard Bruin, Nicolas Thomas, Ivette Alarcon, Bruno Bieth, Shoba Ravichandran, Alexa B. Kimball   +13 more
wiley   +1 more source

Cardiac structural and functional damage induced and/or increasingly aggravated by aortic valve stenosis. [PDF]

Cardiovasc Diagn Ther
Dandel M.
europepmc   +1 more source

Defining the scope of point‐of‐care ultrasound in internal medicine: a consensus statement by the point‐of‐care special interest group of the Internal Medicine Society of Australia and New Zealand

Internal Medicine Journal, EarlyView.
Abstract Background Point‐of‐care ultrasound (POCUS) complements physical examination to advance diagnosis and treatment in a range of clinical scenarios. However, the scope for adult internal medicine physicians is not defined in Australia and New Zealand.
Ximena Cid‐Serra, Harry Gibbs, Nicolas Szecket, Drew Comeau, Patrick Elliott, Victor Duong, Padeepa Perera, Peter Thorson, Ronan O'Donovan, Graeme Maguire, Rattanak Visal Hean, Elizabeth Potter   +11 more
wiley   +1 more source

Could the Hemodynamic Progression of Aortic Valve Stenosis be Slowed Pharmacologically? The Unsolved Dilemma. [PDF]

Rev Cardiovasc Med
Santangelo G, Antonini-Canterin F, Faggiano P.   +2 more
europepmc   +1 more source